Akebia Therapeutics, Inc. (AKBA)
1.19
-0.06
(-4.80%)
USD |
NASDAQ |
Mar 05, 16:00
1.25
+0.06
(+5.04%)
Pre-Market: 08:04
Akebia Therapeutics Cash from Investing (TTM) : -7.926M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Corcept Therapeutics, Inc. | 69.76M |
| MannKind Corp. | -304.80M |
| Ligand Pharmaceuticals, Inc. | -377.32M |
| Ardelyx, Inc. | -8.959M |
| Rhythm Pharmaceuticals, Inc. | -137.15M |